-The Indian Express The latest NSSO data also underlines the increasing absence of women from the labour market Every time results from one of the "thick" rounds of the National Sample Survey come out, we get into a feeding frenzy, trying to slice and dice the statistics for changes since the previous round. Since NSS large rounds are typically conducted every five years, there is perhaps some sense to it, particularly when...
More »SEARCH RESULT
The untold story from Uttarakhand-Ravi Chopra
-The Hindu While the focus is on pilgrims, nobody is talking about the fate of boys and men who came from their villages in the Mandakini valley to earn during the yatri season It is one week since Uttarakhand's worst disaster in living memory. Flash floods resulting from extremely intense rainfall swept away mountainsides, villages and towns, thousands of people, animals, agricultural fields, irrigation canals, domestic water sources, dams, roads, bridges, and...
More »Why tuberculosis is India's biggest public health problem-Ullekh NP
-The Economic Times Anshu Prakash is worried about what he calls "mischievous propaganda" by "some people" who he thinks are misleading reporters. The joint secretary at the ministry of health and family welfare starts off by flatly denying that the joint monitoring mission (JMM) set up by the World Health Organization (WHO) and the government of India (GoI) discussed the impending danger of a TB drugs stock-out in August 2012. "There was...
More »UN warns India against disaster risks in major PPP projects -Pradeep Thakur
-The Times of India NEW DELHI: A United Nations (UN) report has warned India that it is at greater risk by opting for public private partnership (PPP) mode of investment for raising its public infrastructure where the government has less control over its executing private partners and the latter has little interest in long term safety of the projects. A UN study, the Global Assessment Report (GAR) on disaster risk reduction, released...
More »Govt bans common painkiller
-The Telegraph The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage. The health ministry, in a drug withdrawal notification, has suspended the manufacture, distribution and sale of all medicines containing DPPP saying the central government has determined that this drug is likely to involve risk to humans...
More »